Glucosuria with Normal A1C in Thalassemia: Renal Glucosuria Evaluation
In this 20-year-old female with thalassemia, the glucosuria (100 mg/dL) with normal A1C (4.8%) and normal fasting glucose (89 mg/dL) most likely represents renal glucosuria, and A1C should not be used for diabetes screening due to her hemoglobinopathy—plasma glucose criteria via oral glucose tolerance test (OGTT) is required if diabetes screening is indicated.
Why A1C is Unreliable in Thalassemia
The most critical issue here is that A1C cannot be trusted in thalassemia patients. Multiple ADA guidelines explicitly state that in conditions with altered red blood cell turnover, including hemoglobinopathies like thalassemia, only plasma glucose criteria should be used to diagnose diabetes 1, 2, 3.
The evidence is clear:
- Thalassemia causes increased red blood cell turnover and altered hemoglobin glycation 1
- A1C values can be falsely low or high in thalassemia patients 4, 5
- Marked discordance between A1C and plasma glucose should raise suspicion of hemoglobinopathy interference 1
Interpreting the Current Findings
This patient's presentation suggests renal glucosuria rather than diabetes:
- Normal fasting glucose (89 mg/dL)
- Low-normal A1C (4.8%) - though unreliable in thalassemia
- Isolated glucosuria (100 mg/dL in urine)
Recommended Workup
1. Perform a 75-gram OGTT 1, 6, 3
This is the definitive test for diabetes screening in thalassemia patients:
Diagnostic thresholds:
- Diabetes: Fasting ≥126 mg/dL OR 2-hour ≥200 mg/dL 6
- Prediabetes: Fasting 100-125 mg/dL OR 2-hour 140-199 mg/dL 3
Recent research specifically in thalassemia patients shows that dynamic OGTT-derived indices outperform fasting measures for detecting dysglycemia 7. The 1-hour post-load glucose >155 mg/dL and 30-minute glucose are particularly useful risk markers 8.
2. Assess for Renal Glucosuria
If OGTT is normal, confirm benign renal glucosuria:
- Repeat random urine glucose on multiple occasions to confirm persistent glucosuria
- Check serum creatinine and calculate eGFR
- Urinalysis for proteinuria (to exclude broader tubular dysfunction)
- Consider 24-hour urine glucose quantification if diagnosis unclear
3. Evaluate Iron Overload Status (relevant to thalassemia complications)
Even though not directly related to glucosuria, assess:
- Serum ferritin (target <1000 μg/L, ideally <500 μg/L)
- Liver function tests
- Consider cardiac MRI T2* if ferritin elevated
Clinical Pitfalls to Avoid
Never use A1C alone for diabetes diagnosis in thalassemia - this is the most common error 1, 2, 4
Don't assume glucosuria equals diabetes - with normal fasting glucose, renal glucosuria is more likely
Don't use point-of-care A1C testing - even laboratory A1C is unreliable in hemoglobinopathies 3
Consider alternative glycemic markers if needed for monitoring (not diagnosis):
When to Worry About Diabetes in Thalassemia
Thalassemia patients are at increased risk for glucose abnormalities due to:
- Iron deposition in pancreatic beta cells
- Chronic transfusion-related iron overload 11
- Insulin resistance and beta-cell dysfunction 7
Red flags requiring immediate OGTT:
- Fasting glucose ≥100 mg/dL
- Classic hyperglycemic symptoms (polyuria, polydipsia, weight loss)
- Family history of diabetes
- Poor iron chelation compliance
- Age >10 years with transfusion-dependent thalassemia
Bottom Line Algorithm
- Confirm persistent glucosuria (repeat urine glucose)
- Perform 75-gram OGTT (mandatory in thalassemia for diabetes screening)
- If OGTT normal → Diagnose benign renal glucosuria, no further workup needed
- If OGTT abnormal → Diagnose diabetes/prediabetes using plasma glucose criteria only
- Never use A1C for diagnosis in this patient
The urine glucose guideline states that urine glucose testing is not recommended for routine diabetes care 12, but in this case, the incidental finding of glucosuria with normal plasma glucose points toward a renal threshold issue rather than systemic hyperglycemia.